Company Update (NYSE:ACT): (OFFICIAL)-UPDATE 1-Actavis’ superbug antibiotic gets U.S. approval (Feb. 25)

[Reuters – UK Focus] – The U.S. Food and Drug Administration on Wednesday approved the use of Actavis Plc (NYSE: ACT – news) ‘s antibiotic, Avycaz, to battle drug-resistant bacteria known as superbugs. . . . → Read More: Company Update (NYSE:ACT): (OFFICIAL)-UPDATE 1-Actavis’ superbug antibiotic gets U.S. approval (Feb. 25) Similar Articles: Stock Update: Actavis plc (NYSE:ACT) – Actavis to Divest Pharmatech to TPG Stock Update (NYSE:ACT): Actavis to Acquire Auden Mckenzie for 306M GBP Company Update: Actavis plc (NYSE:ACT) – Actavis Launches U.S. Generic Specialty Injectable Portfolio